世界の球脊髄性筋萎縮症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Spinal and Bulbar Muscular Atrophy Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-6018
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、95ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、球脊髄性筋萎縮症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（5α-レダクターゼ阻害剤、ゴナドトロピン放出ホルモンアゴニスト）、用途別市場規模（病院、整形外科クリニック、外来手術センター）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・球脊髄性筋萎縮症治療の市場動向
・企業の競争状況、市場シェア
・球脊髄性筋萎縮症治療の種類別市場規模と予測2016-2027（5α-レダクターゼ阻害剤、ゴナドトロピン放出ホルモンアゴニスト）
・球脊髄性筋萎縮症治療の用途別市場規模と予測2016-2027（病院、整形外科クリニック、外来手術センター）
・球脊髄性筋萎縮症治療の北米市場規模2016-2027（アメリカ、カナダ）
・球脊髄性筋萎縮症治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・球脊髄性筋萎縮症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・球脊髄性筋萎縮症治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・球脊髄性筋萎縮症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（AbbVie、Pfizer、GlaxoSmithKline、Johnson & Johnson、Century Pharmaceuticals、Astellas Pharma、Sanofi、Boehringer Ingelheim International）
・結論

SBMA, mainly manifested as systemic muscle atrophy, paralysis and systemic muscle bundle tremor, patients with systemic muscle weakness, especially the weakness of the two lower limbs to walk, tongue muscle atrophy is usually one of the main symptoms.

Market Analysis and Insights: Global Spinal and Bulbar Muscular Atrophy Treatment Market
The global Spinal and Bulbar Muscular Atrophy Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Spinal and Bulbar Muscular Atrophy Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Spinal and Bulbar Muscular Atrophy Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Spinal and Bulbar Muscular Atrophy Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Spinal and Bulbar Muscular Atrophy Treatment market.

Global Spinal and Bulbar Muscular Atrophy Treatment Scope and Market Size
Spinal and Bulbar Muscular Atrophy Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Spinal and Bulbar Muscular Atrophy Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
5α-Reductase Inhibitors
Gonadotropin-releasing Hormone Agonists

Segment by Application
Hospitals
Orthopedic Clinics
Ambulatory Surgical Centers

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AbbVie
Pfizer
GlaxoSmithKline
Johnson & Johnson
Century Pharmaceuticals
Astellas Pharma
Sanofi
Boehringer Ingelheim International

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 5α-Reductase Inhibitors
1.2.3 Gonadotropin-releasing Hormone Agonists
1.3 Market by Application
1.3.1 Global Spinal and Bulbar Muscular Atrophy Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Orthopedic Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Spinal and Bulbar Muscular Atrophy Treatment Market Perspective (2016-2027)
2.2 Spinal and Bulbar Muscular Atrophy Treatment Growth Trends by Regions
2.2.1 Spinal and Bulbar Muscular Atrophy Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Spinal and Bulbar Muscular Atrophy Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Spinal and Bulbar Muscular Atrophy Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Spinal and Bulbar Muscular Atrophy Treatment Industry Dynamic
2.3.1 Spinal and Bulbar Muscular Atrophy Treatment Market Trends
2.3.2 Spinal and Bulbar Muscular Atrophy Treatment Market Drivers
2.3.3 Spinal and Bulbar Muscular Atrophy Treatment Market Challenges
2.3.4 Spinal and Bulbar Muscular Atrophy Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Spinal and Bulbar Muscular Atrophy Treatment Players by Revenue
3.1.1 Global Top Spinal and Bulbar Muscular Atrophy Treatment Players by Revenue (2016-2021)
3.1.2 Global Spinal and Bulbar Muscular Atrophy Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Spinal and Bulbar Muscular Atrophy Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Spinal and Bulbar Muscular Atrophy Treatment Revenue
3.4 Global Spinal and Bulbar Muscular Atrophy Treatment Market Concentration Ratio
3.4.1 Global Spinal and Bulbar Muscular Atrophy Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Spinal and Bulbar Muscular Atrophy Treatment Revenue in 2020
3.5 Spinal and Bulbar Muscular Atrophy Treatment Key Players Head office and Area Served
3.6 Key Players Spinal and Bulbar Muscular Atrophy Treatment Product Solution and Service
3.7 Date of Enter into Spinal and Bulbar Muscular Atrophy Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Spinal and Bulbar Muscular Atrophy Treatment Breakdown Data by Type
4.1 Global Spinal and Bulbar Muscular Atrophy Treatment Historic Market Size by Type (2016-2021)
4.2 Global Spinal and Bulbar Muscular Atrophy Treatment Forecasted Market Size by Type (2022-2027)

5 Spinal and Bulbar Muscular Atrophy Treatment Breakdown Data by Application
5.1 Global Spinal and Bulbar Muscular Atrophy Treatment Historic Market Size by Application (2016-2021)
5.2 Global Spinal and Bulbar Muscular Atrophy Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size (2016-2027)
6.2 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type
6.2.1 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2016-2021)
6.2.2 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2022-2027)
6.2.3 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2016-2027)
6.3 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application
6.3.1 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2016-2021)
6.3.2 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2022-2027)
6.3.3 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2016-2027)
6.4 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country
6.4.1 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2016-2021)
6.4.2 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size (2016-2027)
7.2 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type
7.2.1 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2016-2021)
7.2.2 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2022-2027)
7.2.3 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2016-2027)
7.3 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application
7.3.1 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2016-2021)
7.3.2 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2022-2027)
7.3.3 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2016-2027)
7.4 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country
7.4.1 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2016-2021)
7.4.2 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size (2016-2027)
8.2 Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type
8.2.1 Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application
8.3.1 Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Region
8.4.1 Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size (2016-2027)
9.2 Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type
9.2.1 Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2016-2027)
9.3 Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application
9.3.1 Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2016-2027)
9.4 Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country
9.4.1 Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size (2016-2027)
10.2 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type
10.2.1 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application
10.3.1 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country
10.4.1 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Spinal and Bulbar Muscular Atrophy Treatment Introduction
11.1.4 AbbVie Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021)
11.1.5 AbbVie Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Spinal and Bulbar Muscular Atrophy Treatment Introduction
11.2.4 Pfizer Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Spinal and Bulbar Muscular Atrophy Treatment Introduction
11.3.4 GlaxoSmithKline Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021)
11.3.5 GlaxoSmithKline Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Spinal and Bulbar Muscular Atrophy Treatment Introduction
11.4.4 Johnson & Johnson Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021)
11.4.5 Johnson & Johnson Recent Development
11.5 Century Pharmaceuticals
11.5.1 Century Pharmaceuticals Company Details
11.5.2 Century Pharmaceuticals Business Overview
11.5.3 Century Pharmaceuticals Spinal and Bulbar Muscular Atrophy Treatment Introduction
11.5.4 Century Pharmaceuticals Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021)
11.5.5 Century Pharmaceuticals Recent Development
11.6 Astellas Pharma
11.6.1 Astellas Pharma Company Details
11.6.2 Astellas Pharma Business Overview
11.6.3 Astellas Pharma Spinal and Bulbar Muscular Atrophy Treatment Introduction
11.6.4 Astellas Pharma Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021)
11.6.5 Astellas Pharma Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Spinal and Bulbar Muscular Atrophy Treatment Introduction
11.7.4 Sanofi Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021)
11.7.5 Sanofi Recent Development
11.8 Boehringer Ingelheim International
11.8.1 Boehringer Ingelheim International Company Details
11.8.2 Boehringer Ingelheim International Business Overview
11.8.3 Boehringer Ingelheim International Spinal and Bulbar Muscular Atrophy Treatment Introduction
11.8.4 Boehringer Ingelheim International Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021)
11.8.5 Boehringer Ingelheim International Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of 5α-Reductase Inhibitors
Table 3. Key Players of Gonadotropin-releasing Hormone Agonists
Table 4. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Spinal and Bulbar Muscular Atrophy Treatment Market Share by Regions (2016-2021)
Table 8. Global Spinal and Bulbar Muscular Atrophy Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Spinal and Bulbar Muscular Atrophy Treatment Market Share by Regions (2022-2027)
Table 10. Spinal and Bulbar Muscular Atrophy Treatment Market Trends
Table 11. Spinal and Bulbar Muscular Atrophy Treatment Market Drivers
Table 12. Spinal and Bulbar Muscular Atrophy Treatment Market Challenges
Table 13. Spinal and Bulbar Muscular Atrophy Treatment Market Restraints
Table 14. Global Spinal and Bulbar Muscular Atrophy Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Spinal and Bulbar Muscular Atrophy Treatment Market Share by Players (2016-2021)
Table 16. Global Top Spinal and Bulbar Muscular Atrophy Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Spinal and Bulbar Muscular Atrophy Treatment as of 2020)
Table 17. Ranking of Global Top Spinal and Bulbar Muscular Atrophy Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Spinal and Bulbar Muscular Atrophy Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Spinal and Bulbar Muscular Atrophy Treatment Product Solution and Service
Table 21. Date of Enter into Spinal and Bulbar Muscular Atrophy Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Spinal and Bulbar Muscular Atrophy Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Spinal and Bulbar Muscular Atrophy Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Spinal and Bulbar Muscular Atrophy Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Spinal and Bulbar Muscular Atrophy Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Spinal and Bulbar Muscular Atrophy Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Spinal and Bulbar Muscular Atrophy Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. AbbVie Company Details
Table 62. AbbVie Business Overview
Table 63. AbbVie Spinal and Bulbar Muscular Atrophy Treatment Product
Table 64. AbbVie Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021) & (US$ Million)
Table 65. AbbVie Recent Development
Table 66. Pfizer Company Details
Table 67. Pfizer Business Overview
Table 68. Pfizer Spinal and Bulbar Muscular Atrophy Treatment Product
Table 69. Pfizer Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021) & (US$ Million)
Table 70. Pfizer Recent Development
Table 71. GlaxoSmithKline Company Details
Table 72. GlaxoSmithKline Business Overview
Table 73. GlaxoSmithKline Spinal and Bulbar Muscular Atrophy Treatment Product
Table 74. GlaxoSmithKline Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021) & (US$ Million)
Table 75. GlaxoSmithKline Recent Development
Table 76. Johnson & Johnson Company Details
Table 77. Johnson & Johnson Business Overview
Table 78. Johnson & Johnson Spinal and Bulbar Muscular Atrophy Treatment Product
Table 79. Johnson & Johnson Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021) & (US$ Million)
Table 80. Johnson & Johnson Recent Development
Table 81. Century Pharmaceuticals Company Details
Table 82. Century Pharmaceuticals Business Overview
Table 83. Century Pharmaceuticals Spinal and Bulbar Muscular Atrophy Treatment Product
Table 84. Century Pharmaceuticals Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021) & (US$ Million)
Table 85. Century Pharmaceuticals Recent Development
Table 86. Astellas Pharma Company Details
Table 87. Astellas Pharma Business Overview
Table 88. Astellas Pharma Spinal and Bulbar Muscular Atrophy Treatment Product
Table 89. Astellas Pharma Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021) & (US$ Million)
Table 90. Astellas Pharma Recent Development
Table 91. Sanofi Company Details
Table 92. Sanofi Business Overview
Table 93. Sanofi Spinal and Bulbar Muscular Atrophy Treatment Product
Table 94. Sanofi Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021) & (US$ Million)
Table 95. Sanofi Recent Development
Table 96. Boehringer Ingelheim International Company Details
Table 97. Boehringer Ingelheim International Business Overview
Table 98. Boehringer Ingelheim International Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021) & (US$ Million)
Table 99. Boehringer Ingelheim International Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Spinal and Bulbar Muscular Atrophy Treatment Market Share by Type: 2020 VS 2027
Figure 2. 5α-Reductase Inhibitors Features
Figure 3. Gonadotropin-releasing Hormone Agonists Features
Figure 4. Global Spinal and Bulbar Muscular Atrophy Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Orthopedic Clinics Case Studies
Figure 7. Ambulatory Surgical Centers Case Studies
Figure 8. Spinal and Bulbar Muscular Atrophy Treatment Report Years Considered
Figure 9. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Spinal and Bulbar Muscular Atrophy Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global Spinal and Bulbar Muscular Atrophy Treatment Market Share by Regions (2022-2027)
Figure 13. Global Spinal and Bulbar Muscular Atrophy Treatment Market Share by Players in 2020
Figure 14. Global Top Spinal and Bulbar Muscular Atrophy Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Spinal and Bulbar Muscular Atrophy Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Spinal and Bulbar Muscular Atrophy Treatment Revenue in 2020
Figure 16. Global Spinal and Bulbar Muscular Atrophy Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global Spinal and Bulbar Muscular Atrophy Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Spinal and Bulbar Muscular Atrophy Treatment Market Share by Type (2016-2027)
Figure 20. North America Spinal and Bulbar Muscular Atrophy Treatment Market Share by Application (2016-2027)
Figure 21. North America Spinal and Bulbar Muscular Atrophy Treatment Market Share by Country (2016-2027)
Figure 22. United States Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Share by Type (2016-2027)
Figure 26. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Share by Application (2016-2027)
Figure 27. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Share by Country (2016-2027)
Figure 28. Germany Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Share by Region (2016-2027)
Figure 38. China Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Share by Type (2016-2027)
Figure 46. Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Share by Application (2016-2027)
Figure 47. Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Share by Country (2016-2027)
Figure 48. Mexico Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Share by Country (2016-2027)
Figure 54. Turkey Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. AbbVie Revenue Growth Rate in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021)
Figure 58. Pfizer Revenue Growth Rate in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021)
Figure 59. GlaxoSmithKline Revenue Growth Rate in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021)
Figure 60. Johnson & Johnson Revenue Growth Rate in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021)
Figure 61. Century Pharmaceuticals Revenue Growth Rate in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021)
Figure 62. Astellas Pharma Revenue Growth Rate in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021)
Figure 63. Sanofi Revenue Growth Rate in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021)
Figure 64. Boehringer Ingelheim International Revenue Growth Rate in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size, Status and Forecast 2021-2027
QFJ1-5351 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、脊髄性筋萎縮症（SMA）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ヌシネルセン、オナセムノゲンアベパルボベック）、用途別市場規模（タイプ1SMA、タイプ2 SMA、その他）、主要地域別市場規...

世界の多系統萎縮症治療薬市場規模・現状・予測（2021年-2027年）

Global Multiple System Atrophy Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-4535 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、多系統萎縮症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アンレ-138b、AZD-3241、CS-10BR05、NPT-20011、PBT-434、PD-01）、用途別市場規模（病院、クリニ...

世界のデュシェンヌ型筋ジストロフィー(DMD)治療薬市場規模・現状・予測（2021年-2027年）

Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size, Status and Forecast 2021-2027
QFJ1-5718 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、デュシェンヌ型筋ジストロフィー(DMD)治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（エテプリルセン、デフラザコート、アタルレン）、用途別市場規模（病院、診療所、ホームケア）、主要地域別市場規...

世界の神経変性疾患治療市場規模・現状・予測（2021年-2027年）

Global Neurodegenerative Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4565 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、神経変性疾患治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（神経伝達物質、神経保護剤、生物製剤、その他）、用途別市場規模（多発性硬化症[MS]、アルツハイマー病、パーキンソン病、急性片頭痛、自閉症...

世界の脊椎インプラント＆手術装置市場規模・現状・予測（2021年-2027年）

Global Spinal Implants and Surgery Devices Market Size, Status and Forecast 2021-2027
QFJ1-5350 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、脊椎インプラント＆手術装置の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（脊椎固定術、運動保存/非固定術、脊椎圧迫骨折治療、脊椎減圧術）、用途別市場規模（開腹手術、低侵襲手術）、主要地域別市場規模（北...

世界の脊髄刺激療法市場規模・現状・予測（2021年-2027年）

Global Spinal Cord Stimulation Therapy Market Size, Status and Forecast 2021-2027
QFJ1-5349 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、脊髄刺激療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（充電式、非充電式）、用途別市場規模（病院、外来手術センター）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東...

世界のダイナミック脊椎テザリングシステム市場規模・現状・予測（2021年-2027年）

Global Dynamic Spinal Tethering System Market Size, Status and Forecast 2021-2027
QFJ1-4164 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、ダイナミック脊椎テザリングシステムの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（脊柱側弯症、その他脊椎奇形）、用途別市場規模（病院、外来外科センター、専門クリニック）、主要地域別市場規模（北米、アメ...

世界の脊椎安定化システム市場規模・現状・予測（2021年-2027年）

Global Spinal Stabilization System Market Size, Status and Forecast 2021-2027
QFJ1-4896 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、脊椎安定化システムの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（後棘間スペーサー、椎弓根スクリュー、全椎間関節置換装置）、用途別市場規模（病院、クリニック）、主要地域別市場規模（北米、アメリカ、欧州...

世界の未分化甲状腺がん治療市場規模・現状・予測（2021年-2027年）

Global Anaplastic Thyroid Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3803 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、未分化甲状腺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界のOAB治療市場規模・現状・予測（2021年-2027年）

Global OAB Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5902 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、OAB治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗コリン作用薬、ミラベグロン、ボトックス）、用途別市場規模（特発性過活動膀胱、神経性過活動膀胱）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の脊髄性筋萎縮症（SMA）治療市場規模・現状・予測（2021年-2027年） Spinal muscular atrophy treatment market growth is driven by a significant increase in the number of product launches despite the relative rarity of the disorder and high costs associated with the approved drugs. The treatment of spinal muscular atrophy through the gene therapy drug called Zolgensma…
世界の多系統萎縮症治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Multiple System Atrophy Therapeutics Market The global Multiple System Atrophy Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and h…
世界のデュシェンヌ型筋ジストロフィー(DMD)治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Drugs for Duchenne Muscular Dystrophy (DMD) Market The global Drugs for Duchenne Muscular Dystrophy (DMD) market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in …
世界のダイナミック脊椎テザリングシステム市場規模・現状・予測（2021年-2027年） Dynamic spinal tethering systems are used for the correction of irregular spine in adults as well as pediatrics. The dynamic spinal tethering systems are generally used in the patients suffering from the scoliosis or any other form of the spine deformity. The tether is anchored using the dynamic sys…
世界の脊髄刺激療法市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Spinal Cord Stimulation Therapy Market The global Spinal Cord Stimulation Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data i…